Reply to: IL-26 and the prognosis of hepatocellular carcinoma after resection

To the Editor: We thank Dr. Braillon for the thoughtful remarks regarding prognostic impact of interleukin (IL)-26 on patients with hepatocellular carcinoma (HCC) undergoing surgical resection [1]. This study drew a conclusion that relative high expression of IL-26 is an independent prognostic factor for HCC patients after resection.